F.F. Knapp

2.6k total citations
93 papers, 2.0k citations indexed

About

F.F. Knapp is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F.F. Knapp has authored 93 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Radiology, Nuclear Medicine and Imaging, 15 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F.F. Knapp's work include Radiopharmaceutical Chemistry and Applications (41 papers), Medical Imaging Techniques and Applications (26 papers) and Cardiac Imaging and Diagnostics (14 papers). F.F. Knapp is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (41 papers), Medical Imaging Techniques and Applications (26 papers) and Cardiac Imaging and Diagnostics (14 papers). F.F. Knapp collaborates with scholars based in United States, Germany and United Kingdom. F.F. Knapp's co-authors include M. R. A. Pillai, Sharmila Banerjee, M. M. GOODMAN, Harold J. Nicholas, A.P. Callahan, G. Kirsch, L. John Goad, Saed Mirzadeh, Ashutosh Dash and T. W. Goodwin and has published in prestigious journals such as Chemical Reviews, Journal of Biological Chemistry and Circulation.

In The Last Decade

F.F. Knapp

89 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F.F. Knapp United States 23 1.1k 445 344 285 232 93 2.0k
Tsutomu Sugahara Japan 28 797 0.7× 946 2.1× 344 1.0× 187 0.7× 473 2.0× 154 2.7k
Hua Yang Canada 26 670 0.6× 834 1.9× 421 1.2× 475 1.7× 370 1.6× 92 2.3k
Jacobus D. M. Herscheid Netherlands 25 630 0.6× 509 1.1× 189 0.5× 204 0.7× 435 1.9× 87 1.5k
Frank Brady United States 28 702 0.6× 626 1.4× 222 0.6× 355 1.2× 79 0.3× 70 2.4k
F. F. Knapp United States 37 2.6k 2.3× 933 2.1× 870 2.5× 614 2.2× 118 0.5× 140 4.4k
Shashikanth Ponnala United States 17 689 0.6× 140 0.3× 306 0.9× 306 1.1× 238 1.0× 35 1.1k
Jacques Rousseau Canada 27 524 0.5× 323 0.7× 538 1.6× 147 0.5× 143 0.6× 73 1.8k
Mitsunori Kirihata Japan 27 1.5k 1.4× 435 1.0× 239 0.7× 133 0.5× 651 2.8× 137 2.7k
George D.D. Jones United Kingdom 34 277 0.2× 1.6k 3.6× 369 1.1× 512 1.8× 223 1.0× 91 2.9k
Cristina Rodríguez‐Rodríguez Canada 21 567 0.5× 249 0.6× 246 0.7× 211 0.7× 190 0.8× 64 1.5k

Countries citing papers authored by F.F. Knapp

Since Specialization
Citations

This map shows the geographic impact of F.F. Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.F. Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.F. Knapp more than expected).

Fields of papers citing papers by F.F. Knapp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.F. Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.F. Knapp. The network helps show where F.F. Knapp may publish in the future.

Co-authorship network of co-authors of F.F. Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of F.F. Knapp. A scholar is included among the top collaborators of F.F. Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.F. Knapp. F.F. Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knapp, F.F. & M. Simon. (2023). Standardization of Project Management Practices of Automotive Industry Suppliers. SHILAP Revista de lepidopterología. 17(3). 432–439.
2.
Dash, Ashutosh, F.F. Knapp, & M. Radhakrishna Pillai. (2013). Targeted Radionuclide Therapy - An Overview. Current Radiopharmaceuticals. 6(3). 152–180. 85 indexed citations
3.
McKillop, J. H., J. Martín-Comín, F.F. Knapp, & A. J. Britten. (2007). Highlights of the European Association of Nuclear Medicine Congress, Athens, Greece, 30 September to 4 October 2006. European Journal of Nuclear Medicine and Molecular Imaging. 34(2). 274–293. 3 indexed citations
4.
Knapp, F.F.. (2001). Future Prospects for Medical Radionuclide Production in the High Flux Isotope Reactor (HFIR) at the Oak Ridge National Laboratory(ORNL). Annals of Nuclear Medicine. 14. 3 indexed citations
5.
Phillips, Melissa S., et al.. (2001). Synthesis of a new bisphosphonic acid ligand (SEDP) and preparation of a 188Re-(Sn)SEDP bone seeking radiotracer. Nuclear Medicine and Biology. 28(4). 419–424. 19 indexed citations
7.
Hosono, Masako, Makoto Hosono, Anil K. Mishra, et al.. (2000). Rhenium-188-labeled anti-neural cell adhesion molecule antibodies with 2-iminothiolane modification for targeting small-cell lung cancer. Annals of Nuclear Medicine. 14(3). 173–179. 9 indexed citations
8.
Wunderlich, Gerhard, et al.. (2000). Preparation and biodistribution of rhenium-188 labeled albumin microspheres B 20: a promising new agent for radiotherapy. Applied Radiation and Isotopes. 52(1). 63–68. 35 indexed citations
9.
Stabin, Michael G., Mark Konijnenberg, F.F. Knapp, & Robert H. Spencer. (2000). Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy. Medical Physics. 27(5). 1086–1092. 22 indexed citations
10.
Yu, Junfeng, et al.. (1999). [188Re]rhenium sulfide suspension: a potential radiopharmaceutical for tumor treatment following intra-tumor injection. Nuclear Medicine and Biology. 26(5). 573–579. 21 indexed citations
11.
Bergström, Kim, Christer Halldin, Jukka O. Hiltunen, et al.. (1998). Evaluation and Metabolite Studies of 125I- and 123I-Labelled E-(R,R)-IQNP: Potential Radioligands for Visualization of M1 Muscarinic Acetylcholine Receptors in Brain. Nuclear Medicine and Biology. 25(3). 209–214. 3 indexed citations
12.
Knapp, F.F.. (1998). Rhenium-188 - A Generator-Derived Radioisotope for Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals. 13(5). 337–349. 94 indexed citations
13.
Zamora, Paul O., et al.. (1997). Targeting Peptides for Pleural Cavity Tumor Radiotherapy: Specificity and Dosimetry of Re-188-RC-160. Hybridoma. 16(1). 85–91. 7 indexed citations
14.
Knapp, F.F., et al.. (1997). Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment.. PubMed. 17(3B). 1783–95. 123 indexed citations
15.
Hsieh, Bor‐Tsung, et al.. (1996). Radiolabelling of lipiodol with generator-produced 188Re for hepatic tumor therapy. Applied Radiation and Isotopes. 47(3). 267–271. 29 indexed citations
16.
Kropp, J., F.F. Knapp, K.R. Ambrose, et al.. (1994). Evaluation of pancreatic lipase activity by simple urine analysis after oral administration of a new iodine-131-labeled triglyceride. European Journal of Nuclear Medicine and Molecular Imaging. 21(11). 1227–1230. 2 indexed citations
17.
Kropp, J., Ulrich Koehler, J. Likungu, et al.. (1993). Semiquantitative 15-(p-[I-123]iodophenyl)pentadecanoic acid (IPPA)-SPECT in the detection of coronary artery disease. Annals of Nuclear Medicine. 7. 59–67. 3 indexed citations
18.
Mirzadeh, Saed, et al.. (1992). Spontaneous electrochemical separation of carrier-free {sup 64}Cu and {sup 67}Cu from Zn targets. Journal of Labelled Compounds and Radiopharmaceuticals. 32. 474–476.
19.
Goodman, Mark M., et al.. (1992). Synthesis and evaluation of radioiodinated 2-(2(RS)-aminopropyl)-5-iodothiophenes as brain imaging agents. Journal of Medicinal Chemistry. 35(2). 280–285. 18 indexed citations
20.
Knapp, F.F., et al.. (1969). Sterol Biosynthesis in Sub-Cellular Particles of Higher Plants. PLANT PHYSIOLOGY. 44(3). 442–446. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026